At a glance
ClinicalIndex Comparison RecordN/ACompleted· 101 enrolled
Drug / intervention
Cervical ripeningother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of Cervical Ripening in the Outpatient Setting Using Mifepristone Versus Balloon Catheter: a Randomized Controlled Trial
In Brief
A clinical study evaluating Cervical ripening for Labor; Forced or Induced, Affecting Fetus or Newborn and Labor Onset and Length Abnormalities. Completed, enrolled 101 participants across 1 site.
Detailed Summary
A randomized controlled trial of mifepristone 200mg vs balloon catheter for cervical ripening.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLabor; Forced or Induced, Affecting Fetus or Newborn, Labor Onset and Length Abnormalities
CountriesPortugal
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJan 2020
First PostedFeb 2020
Primary CompletionDec 2022
TodayJul 2026
First PostedFeb 17, 2020
Enrollment StartJan 15, 2020
Primary CompletionDec 30, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 6.4 years ago
Interventions
Cervical ripeningother
Subjects will undergo cervical ripening in the outpatient setting. The patients will then be scheduled to return the next morning for induction of labor.